Healthy Males
3
Pipeline Programs
3
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
3
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Drug Modality Breakdown
Small Molecule
1100%
+ 2 programs with unclassified modality
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Qilu PharmaceuticalQL1203
GenomicsFiribastat
Bausch HealthNaloxone
Clinical Trials (3)
Total enrollment: 12 patients across 3 trials
Comparing the Pharmacokinetic and Safety of QL1203 and Vectibix® in Healthy Males.
Start: Oct 2019Est. completion: Sep 2020
Phase 1Unknown
Evaluation of the PK Profile of Firibastat Following Administration of Firibastat Prototype Tablet Formulations
Start: Feb 2019Est. completion: Jun 201912 patients
Phase 1Completed
Naloxone and Intravenous Methylnaltrexone Effects on Bladder Function
Start: Oct 2002Est. completion: May 2003
Phase 1Completed
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
3 companies competing in this space